A quiet revolution is happening across Indian hospitals. From large corporate hospitals in metros to 50-bed district hospitals in tier 3 cities — administrators, trustees, and medical directors are making one consistent infrastructure decision: switching from oxygen cylinders to on-site PSA oxygen plants.

This is not a trend driven by marketing. It is driven by hard lessons learned during the COVID-19 pandemic, by tightening NABH accreditation requirements, and by compelling financial math that makes on-site oxygen production the rational choice for any hospital serious about its future.

In this article, we explore the real reasons behind this shift — and why it may be time for your hospital to make the same decision.

The COVID-19 Moment That Changed Everything

Before April 2021, oxygen cylinders were simply 'the way things were done' in most Indian hospitals. Then the second wave hit. Demand for medical oxygen surged by 700–900% in a matter of weeks. Cylinder suppliers could not keep up. Tankers broke down. Deliveries were delayed by days.

The hospitals that survived the crisis without oxygen shortages had one thing in common: on-site PSA oxygen generation. Their supply was completely independent of external suppliers. While other hospitals scrambled for cylinders, PSA-equipped hospitals continued running at full capacity.

That single event changed the conversation about on-site oxygen from 'nice to have' to 'we cannot afford not to have it.'

NABH Is Pushing Hospitals Towards On-Site Oxygen

The National Accreditation Board for Hospitals (NABH) has progressively tightened its standards for medical oxygen supply. NABH assessors now look for documented oxygen supply reliability plans, backup systems, and evidence of consistent purity monitoring.

Hospitals relying solely on cylinders face challenges in meeting these requirements. A PSA system with built-in purity monitoring, automatic alerts, and cylinder bank backup meets NABH's oxygen safety standards cleanly and completely.

For hospitals pursuing NABH accreditation or renewal, an on-site PSA plant is no longer optional — it is practically expected.

The Financial Reality Has Become Impossible to Ignore

For years, hospitals avoided PSA investment because of the upfront capital cost. The numbers have changed that conversation.

Consider a 75-bed hospital consuming 150 cubic metres of oxygen per day. At current market rates, cylinder costs run to approximately ?14–18 lakh per year including rental, delivery, and handling. A CistrOx 150 LPM PSA system can be installed for ?30–35 lakh and produces oxygen for an annual operating cost of ?1.5–2 lakh (electricity and maintenance). Payback in under 18 months — and then ?12–16 lakh in savings every year after that.

Over 10 years, the same hospital saves ?1–1.5 crore compared to continuing with cylinders. That is money that could fund a new OT, upgrade ICU equipment, or expand the hospital.

Staff Safety and Cylinder Management Are Real Problems

Hospital administrators who have managed cylinder-based oxygen supply know the operational burden: coordinating with suppliers, tracking inventory, managing the logistics of returning empty cylinders, and ensuring cylinders are stored safely. Every cylinder is a high-pressure vessel — a safety risk if not handled correctly.

Cylinder-related incidents — tipping, valve damage, fire near storage — are not rare events in Indian hospitals. NABH inspection reports regularly cite improper cylinder storage as a finding requiring corrective action.

A PSA plant eliminates all of this. The system runs automatically. Staff press no buttons and lift no cylinders. The only manual intervention required is routine maintenance — which a qualified Cistron service engineer handles under an AMC arrangement.

Tier 2 and Tier 3 Cities: Supply Chain Is Unreliable

In metros, oxygen cylinder delivery is reasonably reliable. In Vijaywada, Tirunelveli, Kochi, Raipur, or Dehradun — it is a different story. Deliveries arrive late. Suppliers run short. Emergency top-ups come with premium pricing.

For hospitals in tier 2 and tier 3 cities, an on-site PSA system is not just financially superior — it is the only way to guarantee 24×7 oxygen availability without depending on a supply chain that may not be reliable on the day you need it most.

Technology Has Made PSA Systems Fully Automatic

Early PSA oxygen systems required manual intervention and had limited monitoring capability. Modern systems like the Cistron CistrOx are fully automatic, PLC-controlled, and equipped with oxygen purity analysers, pressure monitors, and remote alert systems.

The system monitors itself. If purity drops below the set threshold, it triggers an alarm — automatically. If the primary system has an issue, a backup cylinder manifold kicks in — automatically. Your staff do not need to be oxygen engineers. They simply need to know the alarm number to call — and Cistron's 24×7 IVR support answers.

The Growth of Hospital Infrastructure Investment in India

India is in the middle of a significant expansion of its healthcare infrastructure. Ayushman Bharat, state health missions, and private hospital expansion are adding thousands of beds every year. New hospitals are being built to higher standards than ever before.

Architects and hospital consultants who design new hospitals today specify on-site oxygen generation as a standard infrastructure element — not an optional upgrade. New hospitals that open without a PSA system are already considered behind the curve.

Environmental Benefits

Oxygen cylinders have an environmental footprint that is easy to overlook: manufacturing the cylinders, filling them, transporting them by truck, returning empties, refilling — all of this involves energy consumption and carbon emissions. An on-site PSA system produces oxygen using electricity (increasingly from renewable sources in India) with no transportation logistics and no cylinder lifecycle overhead.

For hospitals committed to sustainability reporting and environmental responsibility, switching to on-site oxygen generation is a measurable environmental improvement.

What Cistron Systems Brings to This Transition

Cistron has been at the centre of India's hospital oxygen infrastructure for over 30 years. With 8,500+ installations across the country, we have seen every type of hospital oxygen challenge — and designed the CistrOx series to address them all.

From initial site assessment to installation, commissioning, staff training, and long-term AMC support, Cistron manages the complete transition from cylinders to PSA. We have done this over 8,500 times. We know what works, what does not, and how to make your transition seamless.

Conclusion

Indian hospitals are switching to on-site PSA oxygen plants for reasons that are simultaneously about patient safety, financial responsibility, regulatory compliance, and operational efficiency. The COVID-19 crisis was the catalyst. The economics, NABH standards, and operational advantages are the sustaining reasons.

The question for your hospital is not whether to make this switch — it is when. And the answer, for most hospitals, is: as soon as possible.